Background And Objective: At present, the quality of life (QOL) of nasopharyngeal carcinoma (NPC) patients is assessed with the QOL scales for cancer patients or head and neck cancer patients (QLQ-C30, QLQ-H&N35, and so on), and SF-36 scale, but they are not specific scales for NPC patients. The specific scale for NPC patients (Scale of Quality of Life for Nasopharyngeal Carcinoma, SQOL-NPC) has not been updated. This study was to develop a QOL scale (Quality of Life for Nasopharyngeal Carcinoma, QOL-NPC) for NPC patients in China.
Methods: The pilot scale was formed according to the definition of QOL from WHO and based on interviews with some experts and patients. The data were collected from 433 NPC patients treated in Cancer Center of Sun Yat-sen University from January to February, 2007. The items were preliminarily screened, evaluated, and modified, then selected by the methods of coefficient of variation, correlation analysis, factor analysis, and reliability analysis (the internal consistency Cronbach's coefficients).
Results: QOL-NPC was developed and evaluated. The scale included 30 items in four domains: physical function (PH), psychological function (PS), social function (SF), and side effect (SE).
Conclusion: The QOL-NPC scale might be an effective scale for NPC patients because it is consistent with the WHO definition and connotation of QOL, and contains common issues of NPC patients as well.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Optimizing the cumulative cisplatin dose for concurrent chemoradiotherapy beneficiaries among elderly nasopharyngeal carcinoma patients: a real world study.
Sci Rep
December 2024
Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital and Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, 518116, Guangdong, China.
This study aimed to find a safe and effective cumulative cisplatin dose (CCD) for concurrent chemoradiotherapy (CCRT) beneficiaries among elderly nasopharyngeal carcinoma (NPC) patients. A total of 765 elderly (≥ 60 years old) NPC patients treated with cisplatin-based CCRT and IMRT-alone from 2007 to 2018 were included in this study. RPA-generated risk stratification was used to identify CCRT beneficiaries.
View Article and Find Full Text PDFDosimetric comparison and evaluation of different convergence modes in nasopharyngeal carcinoma using VMAT treatment deliveries.
PeerJ
December 2024
Department of Radiation Oncology, The First Affiliated Hospital of Guangzhou Medical University, GuangZhou, GuangDong, China.
Background: This study investigates the impact of convergence mode (CM) in Eclipse (Varian Medical Systems) on the quality and complexity of volumetric modulated arc therapy (VMAT) plans for nasopharyngeal carcinoma (NPC) patients.
Methods: We retrospectively analyzed data from 21 NPC patients. For each patient, three VMAT plans with different CM settings (Off, On, and Extended) were created using identical optimization objectives.
m6A methylation profiling as a prognostic marker in nasopharyngeal carcinoma: insights from MeRIP-Seq and RNA-Seq.
Front Immunol
December 2024
Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Background: Nasopharyngeal carcinoma (NPC) is a type of malignant tumors commonly found in Southeast Asia and China, with insidious onset and clinical symptoms. N6-methyladenosine (m6A) modification significantly contributes to tumorigenesis and progression by altering RNA secondary structure and influencing RNA-protein binding at the transcriptome level. However, the mechanism and role of abnormal m6A modification in nasopharyngeal carcinoma remain unclear.
View Article and Find Full Text PDF[Performance of multi-modality and multi-classifier fusion models for predicting radiation-induced oral mucositis in patients with nasopharyngeal carcinoma].
Nan Fang Yi Ke Da Xue Xue Bao
December 2024
School of Biomedical Engineering, Southern Medical University, Guangzhou 510515, China.
Article Synopsis
- The study aimed to assess how well different models predict radiation-induced oral mucositis (RIOM) in nasopharyngeal carcinoma patients after radiotherapy.
- Data was collected from 198 NPC patients who experienced RIOM, using various classification models that combined clinical data and radiation dose information.
- The H-MCF model, which merged multiple types of data, outperformed other models with a high accuracy of 85% and strong sensitivity and specificity, suggesting it is effective in predicting severe RIOM.
Tertiary lymphoid structures in nasopharyngeal carcinoma: A multi-institutional study.
Pathol Res Pract
December 2024
Institute of Biomedicine, Pathology, University of Turku and Turku University Central Hospital, Kiinamyllynkatu 10 D 5035, Turku 20520, Finland.
Background: Tertiary lymphoid structures (TLSs) associate with prognosis of many malignancies. However, the clinical significance of TLSs is not well-elucidated in nasopharyngeal carcinoma (NPC) patients.
Material And Methods: In this whole population-based multicenter study, a total of 115 patients treated for NPC were included.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!